The Panitumumab EGFR Complex Reveals a Binding Mechanism That Overcomes Cetuximab Induced Resistance.
Sickmier, E.A., Kurzeja, R.J., Michelsen, K., Vazir, M., Yang, E., Tasker, A.S.(2016) PLoS One 11: e0163366-e0163366
- PubMed: 27658254 
- DOI: 10.1371/journal.pone.0163366
- Primary Citation of Related Structures:  
5SX5, 5SX4 - PubMed Abstract: 
Panitumumab and cetuximab target the epidermal growth factor receptor for the treatment of metastatic colorectal cancer. These therapies provide a significant survival benefit to patients with metastatic colorectal cancer with wild-type RAS. A single ...